Goldiam International has secured export orders worth ₹50 crore from US-based international clients, according to the company's latest regulatory disclosure. The order involves the manufacturing and export of lab-grown diamond-studded gold jewellery, with execution required on or before November 30, 2026. This significant contract win demonstrates the company's strong position in the lab-grown diamond jewellery market and provides near-term order visibility for the business. The company clarified that the ₹50 crore order value does not include its online orders, ensuring transparency in financial reporting.
Goldiam International operates as an integrated manufacturer and exporter of fine diamond jewellery, primarily supplying leading retailers and wholesalers in the US market. As reported by Business Standard, the company recently expanded its presence in India retail for lab-grown diamond jewellery under the brand name ORIGEM. This strategic move into the Indian market represents a key growth initiative for the company's lab-grown diamond business. The company confirmed that its promoters, promoter group and group companies do not have any interest in the entities that awarded the orders, with the transactions not falling under related-party transactions.
The company delivered impressive financial results in Q1 FY27, with consolidated net profit rising 119.59% to ₹73.98 crore and revenue increasing 41.92% to ₹326.03 crore compared to Q1 FY26, according to Business Standard. This substantial growth in both profitability and revenue demonstrates the company's strong operational performance and market demand for its products. The company stated that the export orders are expected to support strong momentum in the near term, indicating positive business outlook.
Despite the positive business developments, the company's stock performance showed mixed results, with the scrip falling 3.34% to currently trade at ₹361.70 on the BSE, as reported by Business Standard. The market reaction suggests investor focus may be on near-term execution challenges rather than the significant export contract win and strong financial performance. However, the company's regulatory disclosure and clarification on order details may provide better market confidence going forward.
